Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gordon

Showing results (941-950 of 1,032) with videos related to

Pageof 104
Sort By:
British Journal of Haematology|January 30, 2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Andrew M Evens, Fangxin Hong, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male SexZheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.
Blood Advances|September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphomaPamela B Allen, Xinyan Lu, Qing Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin LymphomaRadhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Nature Protocols|July 18, 2024
A multi-glycomic platform for the analysis of food carbohydratesGarret Couture, Shawn Ehlers Cheang, Christopher Suarez, et al.
ACS Applied Materials & Interfaces|December 17, 2024
Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1Jonathan S Rink, Adam Y Lin, Andrea E Calvert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approachSwaine L Chen, Chia-Seui Hung, Jian Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2009
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phylaMichael A Mahowald, Federico E Rey, Henning Seedorf, et al.
Science (New York, N.Y.)|February 1, 2013
Gut microbiomes of Malawian twin pairs discordant for kwashiorkorMichelle I Smith, Tanya Yatsunenko, Mark J Manary, et al.
Pageof 104

Showing results (941-950 of 1,032) with videos related to

Sort By:
Pageof 104
British Journal of Haematology|January 30, 2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Andrew M Evens, Fangxin Hong, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male SexZheng Zhou, Alfred W Rademaker, Leo I Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.
Blood Advances|September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphomaPamela B Allen, Xinyan Lu, Qing Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin LymphomaRadhakrishnan Ramchandren, Ranjana H Advani, Stephen M Ansell, et al.
Nature Protocols|July 18, 2024
A multi-glycomic platform for the analysis of food carbohydratesGarret Couture, Shawn Ehlers Cheang, Christopher Suarez, et al.
ACS Applied Materials & Interfaces|December 17, 2024
Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1Jonathan S Rink, Adam Y Lin, Andrea E Calvert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approachSwaine L Chen, Chia-Seui Hung, Jian Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2009
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phylaMichael A Mahowald, Federico E Rey, Henning Seedorf, et al.
Science (New York, N.Y.)|February 1, 2013
Gut microbiomes of Malawian twin pairs discordant for kwashiorkorMichelle I Smith, Tanya Yatsunenko, Mark J Manary, et al.
Pageof 104